Similarly, Coa et al. [126] revealed enhanced expression of FSCN1 in primary mucinous carcinomas in comparison with borderline mucinous tumors with a significant expression in metastatic tumors as compared with primary tumors. The gene discussed is FSCN1; the disease is mucinous adenocarcinoma.